This week, the Bachelor tested positive for COVID-19. As both an avid watcher of the franchise and a COVID-19 reporter, I was immediately curious to see how the production would handle this. Unfortunately, the show was pretty sparse on safety details.
Sources and updates for the week of February 26 include deaths in U.S. prisons, the future of COVID-19 vaccines, airplane wastewater testing, and more.
Last week, I wrote about my experience with a CO2 monitor that I recently bought, and have been using to informally study the air quality in my New York City apartment. I asked readers to share their experiences with these monitors, and several of you did!
This week, I have a new story out in Gothamist and WNYCabout norovirus, a nasty stomach bug that appears to be spreading a lot in the U.S. right now. The story shares some NYC-specific norovirus information, but it also talks more broadly about why it’s difficult to find precise data on this virus despite its major implications for public health. Reporting this story led me to reflect on how COVID-19 has revealed cracks in the country’s infrastructure for tracking a lot of common pathogens.
The national COVID-19 plateau continues. As I’ve been saying for a few weeks now, COVID-19 spread has dropped significantly from its high during the winter holidays, but it has not fallen to the low levels we’ve previously seen this time of year due to a combination of lax precautions and the latest Omicron variant, XBB.1.5.
Political leaders in New York State recently ended a policy requiring masks in healthcare settings. In response to the change, local advocacy organization Mandate Masks NY has compiled a list of hospitals and healthcare centers in New York that are still maintaining mask requirements independently of the state policy.
I recently bought a carbon dioxide monitor, and have been using it to collect data in my apartment and other places. In the week since I’ve been monitoring, I’ve noticed how personal data collection like this can be helpful in identifying ventilation issues, but comes with many caveats.
An interesting question from a reader got me thinking about how, exactly, we track the impacts of Long COVID. Doctors, researchers, and long-haulers themselves have learned a lot about the condition over the last three years. We still don’t have clear estimates of exactly how many people in the U.S. are dealing with this chronic disease, but we’ve come much closer to understanding its impacts than we were when patients first began advocating for themselves in 2020.
Nationally, official COVID-19 cases and hospitalizations continue to trend slowly downward, suggesting that we’re in a high plateau of consistent virus spread. Reported cases have only declined by about 18% in the last month, while new hospital admissions have declined by 28%.